FAQ
Detailed Search
|
Topic: |
Digestive Diseases (DD) |
Title: |
Gallstone Management in Inflammatory Bowel Disease. |
Author: |
Lazaridis, K.N.; Lindor, K.D. |
Source: |
In: Bayless, T.M. and Hanauer, S.B. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, Ontario: B.C. Decker Inc. 2001. p. 317-320. |
Availability: |
Available from B.C. Decker Inc. 20 Hughson Street South, P.O. Box 620, L.C.D. 1 Hamilton, Ontario L8N 3K7. (905) 522-7017 or (800) 568-7281. Fax (905) 522-7839. Email: info@bcdecker.com. Website: www.bcdecker.com. PRICE: $129.00 plus shipping and handling. ISBN: 1550091220. |
Abstract: |
This chapter on gallstone (cholelithiasis) management in inflammatory bowel disease (IBD) is from the second edition of a book devoted to the details of medical, surgical, and supportive management of patients with Crohn's disease (CD) and Ulcerative Colitis (UC), together known as IBD. The association between IBD and hepatobiliary (liver, gallstone, bile ducts) disorders has been well established. Both CD and chronic Ulcerative Colitis (UC) can affect the liver and biliary system. Indeed, hepatobiliary involvement in patients with IBD varies from the asymptomatic state to the development of symptomatic complications related to chronic liver injury. Gallstones represent one of the most frequently encountered clinical hepatobiliary problems in patients with IBD especially those with Crohn's disease. In this chapter, the authors present an overview of the management of gallbladder stones and biliary sludge in patients with IBD. A summary of the epidemiology and pathogenesis of gallstones and biliary sludge in these patients is provided to guide therapeutic decision-making, which should aim not only to address symptomatic stones but also to prevent their development. Precipitating factors or conditions including prolonged fasting, total parenteral nutrition (TPN), and use of the drugs ceftriazone or octreotide must be avoided. Patients with symptomatic sludge or complications should have cholecystectomy (removal of the gallbladder). In poor surgical candidates, alternative interventions include oral agents for bile acid dissolution and percutaneous cholecystostomy. 1 figure. 1 table. 8 references. |
Format: |
Book Chapter |
Language: |
English. |
Major Keywords: |
Digestive System Diseases. Inflammatory Bowel Disease. Ulcerative Colitis. Crohns Disease. Patient Care Management. Complications. Gallstones. |
Minor Keywords: |
Epidemiology. Pathogenesis. Diagnosis. Cholecystectomy. Prevention. Diagnostic Tests. Pathology. Symptoms. Risk Factors. |
Publication Number: |
DDBK08612 |
Printer-Friendly Version | Return to Search Results |
<-- previous record
|
next record -->
|
|
![](edmiimages/dot.gif) |
|